Given President Trump’s boasts about being tough on China, one might imagine that regulators of Chinese drug manufacturing plants would be in a hawkish state of vigilance. Yet in my decade investigating overseas drug manufacturers, I found that the FDA has often been hesitant to enforce its own rules.
↧